
China to establish national rare disease network
pharmafile | February 19, 2019 | News story | Manufacturing and Production |Â Â China, NHC, healthcare, rare diseasesÂ
China is set to establish a national collaborative network of hospitals for rare disease diagnosis and treatment to promote early detection and effective treatment of rare diseases.
The initiative, announced by the National Health Commission, will see 324 hospitals, chosen for their capacity and experience in treating patients with rare disease, participate in the network.
The network will facilitate the timely transfer of difficult and complicated cases between hospitals and the allocation of quality medical resources for patients.
Meanwhile hospitals will be urged to further train doctors and medical workers in dealing with rare diseases with a focus on improving doctor’s abilities to make diagnoses.
The decision comes after the Chinese government cut VAT on 21 drugs for rare diseases causing stocks in Chinese pharmaceutical companies to soar.
Louis Goss
Related Content

Biogen and Stoke report positive results for Dravet syndrome drug
Biogen and Stoke Therapeutics have shared encouraging new data for their experimental treatment, zorevunersen, which …

CARBOGEN AMCIS manufacturing license advances services in China
Swiss pharma manufacturing company, CARBOGEN AMCIS, has announced that its facility in Shanghai, China, has …

ADHD coach and breathwork experts to run workshop for ADHD management
ADHD coach John Harrington and breathwork facilitator Martin O’Toole will collaborate on ‘Breathwork for ADHD …






